ABSCIENCES (EPA:AB) | WebDisclosure

Basculer en Français

9784	Companies
196006	Keywords
127065	Articles
104238	Press releases

Home
Companies
ABSCIENCES

BRIEF

published on 07/08/2025 at 08:06, 6 months 25 days ago

AB Science finalise un placement privé de 1,925 million d'euros

Placement Privé Émission D'actions AB Science Financement Des Biotechnologies Programme AB8939
PRESS RELEASE

published on 07/08/2025 at 08:01, 6 months 25 days ago

AB Science annonce le succès d'un placement privé de 1,925 millions d'euros
AB Science annonce le succès d'un placement privé d'environ 1,925 million d'euros pour financer le développement clinique du programme AB8939

Financement Placement Privé Développement Clinique AB Science Programme AB8939
PRESS RELEASE

published on 07/08/2025 at 08:01, 6 months 25 days ago

AB Science announces the successful completion of a EUR 1.925 million private placement
AB Science successfully completes EUR 1.925 million private placement to finance ongoing activities and focus on AB8939 program development. New shares to be admitted to trading on Euronext Paris

Private Placement Euronext Paris AB Science AB8939 Program EUR 1.925 Million
BRIEF

published on 07/04/2025 at 08:06, 6 months 29 days ago

AB Science : Feu vert pour l'étude de phase 3 du masitinib dans le cancer de la prostate

Phase 3 AB Science Masitinib Cancer De La Prostate FDA Et EMA
BRIEF

published on 07/04/2025 at 08:06, 6 months 29 days ago

AB Science: Green light for phase 3 study of masitinib in prostate cancer

Phase 3 AB Science Masitinib Prostate Cancer FDA And EMA
PRESS RELEASE

published on 07/04/2025 at 08:01, 6 months 29 days ago

AB Science : Le masitinib reçoit l'autorisation de la FDA et de l'EMA pour l’etude confirmatoire de phase 3 dans le cancer de la prostate métastatique hormono-resistant
AB Science obtient l'autorisation de la FDA et de l'EMA pour une étude de phase 3 avec le masitinib dans le cancer de la prostate métastatique hormono-résistant, ciblant une population spécifique de patients

FDA AB Science Masitinib EMA Cancer De La Prostate
BRIEF

published on 07/01/2025 at 10:13, 7 months 1 day ago

Résultats de l'Assemblée Générale d'AB Science

Droits De Vote Capital Social Assemblée Générale Resolutions AB Science
BRIEF

published on 07/01/2025 at 10:13, 7 months 1 day ago

Results of the AB Science General Meeting

Share Capital Voting Rights Resolutions General Assembly AB Science
PRESS RELEASE

published on 07/01/2025 at 10:08, 7 months 1 day ago

AB Science : Résultats de l'Assemblée Générale Mixte du 30 juin 2025
L'Assemblée Générale Mixte de AB Science du 30 juin 2025 a approuvé toutes les résolutions sauf une. Détails des votes et résultats. Fondée en 2001, AB Science se spécialise dans les IPK

Assemblée Générale Mixte Pharmaceutique Résolutions Adoptées AB Science Protéines Kinases
BRIEF

published on 06/30/2025 at 08:08, 7 months 2 days ago

AB Science obtient un report de remboursement de prêt de deux ans

Stratégie Financière Restructuration De La Dette AB Science Report De Prêt Accord Des Créanciers

Accesswire

Published on 02/02/2026 at 23:55, 4 hours 59 minutes ago

2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 4 hours 59 minutes ago

55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 5 hours 29 minutes ago

Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 6 hours 49 minutes ago

Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 13 hours 54 minutes ago

Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform

View all ACCESSWIRE

EQS Group

Published on 02/02/2026 at 20:00, 8 hours 54 minutes ago

CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 8 hours 57 minutes ago

US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 9 hours 11 minutes ago

EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 9 hours 49 minutes ago

Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 19:00, 9 hours 54 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 02/02/2026 at 18:23, 10 hours 31 minutes ago

Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 10 hours 31 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 10 hours 54 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 10 hours 54 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 10 hours 54 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE